Insider Shareholders with Direct Ownership of Pliant Therapeutics, Inc. (PLRX)
This section provides a comprehensive overview of the insiders with direct ownership of Pliant Therapeutics, Inc. (PLRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
PLIANT THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Third Rock Ventures Iii, L.P.
> 10% Shareholder |
5,559,440 | 4,000,000 | 1,839,160 $3.38 Million | 3 |
Nov 29, 2022
Reduced 52.09%
|
|
Bernard Coulie
President and CEO |
1,033,575 | 496,551 | 593,017 $1.09 Million | 47 |
Jan 23, 2025
Added 21.51%
|
|
Keith Lamont Cummings
Chief Financial Officer |
419,497 | 128,948 | 319,258 $587,434 | 24 |
Jan 23, 2025
Added 15.07%
|
|
Hans Hull
Chief Business Officer |
235,690 | 104,462 | 251,708 $463,142 | 19 |
Jan 23, 2025
Added 13.76%
|
|
Eric Lefebvre
Chief Medical Officer |
257,113 | 198,545 | 240,224 $442,012 | 19 |
Jan 23, 2025
Added 15.97%
|
|
Mike Ouimette
General Counsel & Corp. Sec'y |
194,828 | 89,284 | 105,544 $194,200 | 19 |
Jan 23, 2025
Added 24.9%
|
|
Lily Cheung
Chief Human Resource Officer |
51,875 | 3,740 | 50,425 $92,782 | 3 |
Jan 23, 2025
Added 33.91%
|